Measurement of left atrial size as a predictor of severity of illness in sickle cell disease.

Atrial Cell Disease Hematology Illness Left Severity Sickle Size Ultrasound

Journal

The American journal of emergency medicine
ISSN: 1532-8171
Titre abrégé: Am J Emerg Med
Pays: United States
ID NLM: 8309942

Informations de publication

Date de publication:
04 Jul 2024
Historique:
received: 17 11 2023
revised: 21 05 2024
accepted: 02 07 2024
medline: 20 7 2024
pubmed: 20 7 2024
entrez: 19 7 2024
Statut: aheadofprint

Résumé

Sickle cell disease (SCD) is characterized by microvascular occlusion which leads to multiorgan damage, including left ventricular diastolic dysfunction. Left ventricular diastolic dysfunction has been shown to be an independent risk factor for death in SCD patients. Left atrial dilation (LAD) has been used as a surrogate marker for identification of left ventricular diastolic dysfunction. Investigate the association of LAD, as determined by echocardiography, with increased disease burden in SCD as reflected by increased emergency department (ED) utilization, increased hemolysis markers, and worsening anemia. A retrospective cohort study of patients from a single university hospital were selected from a national registry. Age, sickle cell phenotype, echocardiogram findings, ED utilization, baseline hemoglobin, and lab values needed for calculation of hemolytic index were recorded for each patient. Patients were then stratified into two distinct groups based on the presence or absence of LAD to compare ED utilization, baseline hemoglobin and hemolytic index between the two groups. 129 patients met the criteria for inclusion with 88 having normal left atrial volume and 41 with LAD. There was a higher percentage of high ED utilizers in the LAD group compared to the normal left atrial volume group [34% vs. 17%, p = 0.03]. Average hemoglobin was lower in the LAD group compared with the normal left atrial volume group [mean 8.57 g/dL vs. 9.47 g/dL, p = 0.011]. The mean hemolytic index was higher in the LAD group when compared with the normal left atrial volume group [0.44 vs. -0.21, p < 0.001]. LAD was associated with higher ED utilization, lower hemoglobin level, and more hemolysis in patients with SCD.

Sections du résumé

BACKGROUND BACKGROUND
Sickle cell disease (SCD) is characterized by microvascular occlusion which leads to multiorgan damage, including left ventricular diastolic dysfunction. Left ventricular diastolic dysfunction has been shown to be an independent risk factor for death in SCD patients. Left atrial dilation (LAD) has been used as a surrogate marker for identification of left ventricular diastolic dysfunction.
OBJECTIVE OBJECTIVE
Investigate the association of LAD, as determined by echocardiography, with increased disease burden in SCD as reflected by increased emergency department (ED) utilization, increased hemolysis markers, and worsening anemia.
METHODS METHODS
A retrospective cohort study of patients from a single university hospital were selected from a national registry. Age, sickle cell phenotype, echocardiogram findings, ED utilization, baseline hemoglobin, and lab values needed for calculation of hemolytic index were recorded for each patient. Patients were then stratified into two distinct groups based on the presence or absence of LAD to compare ED utilization, baseline hemoglobin and hemolytic index between the two groups.
RESULTS RESULTS
129 patients met the criteria for inclusion with 88 having normal left atrial volume and 41 with LAD. There was a higher percentage of high ED utilizers in the LAD group compared to the normal left atrial volume group [34% vs. 17%, p = 0.03]. Average hemoglobin was lower in the LAD group compared with the normal left atrial volume group [mean 8.57 g/dL vs. 9.47 g/dL, p = 0.011]. The mean hemolytic index was higher in the LAD group when compared with the normal left atrial volume group [0.44 vs. -0.21, p < 0.001].
CONCLUSIONS CONCLUSIONS
LAD was associated with higher ED utilization, lower hemoglobin level, and more hemolysis in patients with SCD.

Identifiants

pubmed: 39029279
pii: S0735-6757(24)00317-6
doi: 10.1016/j.ajem.2024.07.001
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

126-128

Informations de copyright

Copyright © 2024 The Authors. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest None of the above listed authors have any conflicts of interest to report.

Auteurs

Farrah Shahrzad Nasrollahi (FS)

University of Illinois, Department of Emergency Medicine, Chicago, IL, USA.

Dino J Gutierrez (DJ)

University of Illinois, College of Medicine, Chicago, IL, USA. Electronic address: dgutie24@uic.edu.

Judith Nocek (J)

University of Illinois, Department of Medicine, Sickle Cell Center, Chicago, IL, USA.

Jennifer Folami (J)

University of Illinois, College of Medicine, Rockford, IL, USA.

Sahrish Ekram (S)

University of Illinois, Department of Emergency Medicine, Chicago, IL, USA.

Wesley Eilbert (W)

University of Illinois, Department of Emergency Medicine, Chicago, IL, USA.

Joseph S Colla (JS)

University of Illinois, Department of Emergency Medicine, Chicago, IL, USA.

Classifications MeSH